Investors Research Corp »

Adaptimmune Therapeutics shares owned by Investors Research Corp

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Investors Research Corp from 13F filings

Historical chart of Investors Research Corp investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Investors Research Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Investors Research Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $79 100 0.79
2023-09-30 $78 100 0.78
2023-06-30 $185 200 0.93

More positions owned by Investors Research Corp

Ishares Tr Rus Tp200 Gr Etf (IWY)
Spdr Ser Tr Portfoli S&p1500 (SPTM)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr S&p 100 Etf (OEF)
Vanguard Index Fds Large Cap Etf (VV)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Victory Portfolios Ii Vicshs Dv Ac Etf (VSDA)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Fidelity Covington Trust Msci Hlth Care I (FHLC)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Select Sector Spdr Tr Energy (XLE)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T Hig Yld Eq Div (PEY)

View all positions for Investors Research Corp

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
GSA Capital Partners
Acuitas Investments
Millennium Management
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics